CD70 CAR-T by UTC Therapeutics for Mantle Cell Lymphoma: Likelihood of Approval

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in the Phase II in clinical pathway.

Aug 10, 2023 - 20:00
CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in the Phase II in clinical pathway.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow